Public Pharma for Europe, a Game-Changer for Access to Medicines
A growing number of organizations in Europe is demanding a complete overhaul of regional pharma policies in order to protect people’s health over profits
A growing number of organizations in Europe is demanding a complete overhaul of regional pharma policies in order to protect people’s health over profits
"Pfizer treats Paxlovid like a Prada handbag; a luxury for the few rather than a treatment for the many," said one consumer advocate.
Health insurance CEOs pocket millions while citizens can’t pay the out-of-pocket.
Monopoly pricing and corporate greed are destroying healthcare systems in the UK and globally.